OurCrowd Qure

OurCrowd Qure is a global venture fund specializing in healthcare investments, operating as part of the OurCrowd platform. The fund focuses on early-stage investments in digital health startups, aiming to revolutionize healthcare through innovative technologies. OurCrowd Qure was launched in November 2016 and is managed by Allen Kamer and Dr. Yossi Bahagon, both experienced professionals in the digital health sector. The fund has established strategic partnerships with key stakeholders in consumer, provider, payer, and pharmaceutical domains, providing fast-track access to market and clinical validation opportunities for its portfolio companies.

The fund's investment strategy emphasizes sectors such as medical devices, biotechnology, pharmaceuticals, medical imaging, telemedicine, health IT, diagnostics, wearables, health data analytics, health services, medical equipment, health insurance, and pharmaceutical distribution. By targeting these areas, OurCrowd Qure aims to support companies that are developing disruptive solutions to improve healthcare delivery and outcomes.

OurCrowd Qure has a track record of leading investments in several notable digital health companies. For instance, in January 2017, the fund led a $5.1 million funding round for DarioHealth Corp., a company specializing in digital health self-management solutions. Additionally, in May 2017, OurCrowd invested $2.5 million in Scopio Labs, a company developing next-generation digital microscopes based on computational imaging breakthroughs. These investments reflect the fund's commitment to supporting innovative healthcare technologies that have the potential to transform the industry.